Synergistic Inhibition of Drug Resistant KRAS Mutant Non-Small Cell Lung Cancer by Co-Targeting AXL and SRC is a research paper published in Cancers (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NIH R01-CA274677-01
National Institutes of Health
Grant: 1R01CA274677-01
Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC
NCI NIH HHS
Grant: R01 CA274677
NIH HHS
Grant: R01-CA274677-03
FWCI
1.13
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords